TIZZANI, Alessandro
TIZZANI, Alessandro
125I brachytherapy for localized prostate cancer: a single institution experience
2013-01-01 Guarneri A; Botticella A; Filippi AR; Munoz F; Beltramo G; Casetta G; Giglioli FR; Tizzani A; Ragona R; Ricardi U.
[A case of percutaneous translumbar clearance of an obstructed ureterocutaneostomy]
1984-01-01 DEFILIPPI C ;GANDINI G ;RIGHI D ;CARONE R ;FREA B ;TIZZANI A
[A new needle-catheter for percutaneous pyelostomy]
1983-01-01 DEFILIPPI C ;GANDINI G ;RIGHI D ;FREA B ;TIZZANI A ;CARONE R
[Note on a personal technic for percutaneous and endoscopic placement of a double J urinary prosthesis]
1983-01-01 DEFILIPPI C ;GANDINI G ;RIGHI D ;FREA B ;TIZZANI A ;CARONE R
[Screening for prostate cancer: reasons for, reasons against]
1999-01-01 Tizzani A; Casetta G; Gontero P.
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine
2008-01-01 Paolo Gontero; Luigi Cattel; Tonia C. Paone; Giovanna Berta; Paola Milla; Francesco Carbone; Claudio Medana; Alessandro Tizzani
A pharmacokinetics study to optimize intravesical administration of gemcitabine
2009-01-01 Paolo Gontero; Luigi Cattel; Giovanna Berta; Tonia C. Paone; Paola Milla; Claudio Medana; Francesco Carbone; Alessandro Tizzani
A pilot phase-II prospective study to test the 'efficacy' and tolerability of a penile-extender device in the treatment of 'short penis'
2009-01-01 Gontero P; Di Marco M; Giubilei G; Bartoletti R; Pappagallo G; Tizzani A; Mondaini N
Ablative therapies in the treatment of small renal tumors: how far from standard of care?
2010-01-01 Gontero P; Joniau S; Zitella A; Tailly T; Tizzani A; Van Poppel H; Kirkali Z
Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer
2007-01-01 CHIAPPINO I; DESTEFANIS P; ADDEO A; GALETTO A; CUCCHIARALE G; MUNOZ F; ZITELLA A; FERRANDO U; FONTANA D; RICARDI U; TIZZANI A; BERTETTO O
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study.
2011-01-01 P. Gontero; M. Oderda; V. Altieri; R. Bartoletti; T. Cai; R. Colombo; A. Curotto; S. Di Stasi; M. Maffezzini; S. Tamagno; V. Serretta; F. Sogni; C. Terrone; A. Tizzani; G. Morgia; V. Mirone; G. Carmignani
Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation
2009-01-01 Garetto S; Sizzano F; Brusa D; Tizzani A; Malavasi F; Matera L.
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.
2001-01-01 PRIOLO G; GONTERO P; MARTINASSO G; MENGOZZI G; FORMICONI A; PELUCELLI G; ZITELLA A; CASETTA G; VIBERTI L; AIMO G; A. TIZZANI
BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.
2000-01-01 CASETTA G; GONTERO P; ZITELLA A; PELUCELLI G; FORMICONI A; PRIOLO G; MARTINASSO G; MENGOZZI G; AIMO G; VIBERTI L; TIZZANI A
Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits
2005-01-01 Bosio A; Berruti A; Zitella A; Mengozzi G; Destefanis P; Bisconti A; Casetta G; Aimo P; Rolle L; Greco A; Dogliotti L; Fontana D; Tizzani A
Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal.
1998-01-01 BODO G ;GONTERO P ;CASETTA G ;ALPA M ;BROSSA G ;RUSSO R ;TIZZANI A
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison.
2013-01-01 Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia
2007-01-01 ZITELLA A; BERRUTI A; DESTEFANIS P; MENGOZZI G; TORTA M; CERUTI C; CASETTA G; MOSCA A; GRECO A; ROLLE L; AIMO G; AROASIO E; TIZZANI A; DOGLIOTTI L; FONTANA D; GRUPPO ONCOLOGICO UROLOGICO PIEMONTESE GOUP
Confronto tra due metodi per la misura della concentrazione della cromogranina A circolante in pazienti con iperplasia prostatica benigna e adenocarcinoma prostatico
2005-01-01 Destefanis P.; Berruti A.; Zitella A.; Mongozzi G.; Rosso R.; Casetta G.; Aimo P.; Rolle L.; Greco A.; Dogliotti L.; Fontana D.; Tizzani A.
Critical issues in current comparative and cost analyses between retropubic and robotic radical prostatectomy
2008-01-01 GIANINO M; GALZERANO M; TIZZANI A; GONTERO P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 125I brachytherapy for localized prostate cancer: a single institution experience | 2013 | Guarneri A; Botticella A; Filippi AR; Munoz F; Beltramo G; Casetta G; Giglioli FR; Tizzani A; Ragona R; Ricardi U. | |
| [A case of percutaneous translumbar clearance of an obstructed ureterocutaneostomy] | 1984 | DEFILIPPI C ;GANDINI G ;RIGHI D ;CARONE R ;FREA B ;TIZZANI A | |
| [A new needle-catheter for percutaneous pyelostomy] | 1983 | DEFILIPPI C ;GANDINI G ;RIGHI D ;FREA B ;TIZZANI A ;CARONE R | |
| [Note on a personal technic for percutaneous and endoscopic placement of a double J urinary prosthesis] | 1983 | DEFILIPPI C ;GANDINI G ;RIGHI D ;FREA B ;TIZZANI A ;CARONE R | |
| [Screening for prostate cancer: reasons for, reasons against] | 1999 | Tizzani A; Casetta G; Gontero P. | |
| A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine | 2008 | Paolo Gontero; Luigi Cattel; Tonia C. Paone; Giovanna Berta; Paola Milla; Francesco Carbone; Claudio Medana; Alessandro Tizzani | |
| A pharmacokinetics study to optimize intravesical administration of gemcitabine | 2009 | Paolo Gontero; Luigi Cattel; Giovanna Berta; Tonia C. Paone; Paola Milla; Claudio Medana; Francesco Carbone; Alessandro Tizzani | |
| A pilot phase-II prospective study to test the 'efficacy' and tolerability of a penile-extender device in the treatment of 'short penis' | 2009 | Gontero P; Di Marco M; Giubilei G; Bartoletti R; Pappagallo G; Tizzani A; Mondaini N | |
| Ablative therapies in the treatment of small renal tumors: how far from standard of care? | 2010 | Gontero P; Joniau S; Zitella A; Tailly T; Tizzani A; Van Poppel H; Kirkali Z | |
| Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer | 2007 | CHIAPPINO I; DESTEFANIS P; ADDEO A; GALETTO A; CUCCHIARALE G; MUNOZ F; ZITELLA A; FERRANDO U; FONTANA D; RICARDI U; TIZZANI A; BERTETTO O | |
| Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. | 2011 | P. Gontero; M. Oderda; V. Altieri; R. Bartoletti; T. Cai; R. Colombo; A. Curotto; S. Di Stasi; M. Maffezzini; S. Tamagno; V. Serretta; F. Sogni; C. Terrone; A. Tizzani; G. Morgia; V. Mirone; G. Carmignani | |
| Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation | 2009 | Garetto S; Sizzano F; Brusa D; Tizzani A; Malavasi F; Matera L. | |
| Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer. | 2001 | PRIOLO G; GONTERO P; MARTINASSO G; MENGOZZI G; FORMICONI A; PELUCELLI G; ZITELLA A; CASETTA G; VIBERTI L; AIMO G; A. TIZZANI | |
| BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder. | 2000 | CASETTA G; GONTERO P; ZITELLA A; PELUCELLI G; FORMICONI A; PRIOLO G; MARTINASSO G; MENGOZZI G; AIMO G; VIBERTI L; TIZZANI A | |
| Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits | 2005 | Bosio A; Berruti A; Zitella A; Mengozzi G; Destefanis P; Bisconti A; Casetta G; Aimo P; Rolle L; Greco A; Dogliotti L; Fontana D; Tizzani A | |
| Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal. | 1998 | BODO G ;GONTERO P ;CASETTA G ;ALPA M ;BROSSA G ;RUSSO R ;TIZZANI A | |
| Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. | 2013 | Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L | |
| Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia | 2007 | ZITELLA A; BERRUTI A; DESTEFANIS P; MENGOZZI G; TORTA M; CERUTI C; CASETTA G; MOSCA A; GRECO A; ROLLE L; AIMO G; AROASIO E; TIZZANI A; DOGLIOTTI L; FONTANA D; GRUPPO ONCOLOGICO UROLOGICO PIEMONTESE GOUP | |
| Confronto tra due metodi per la misura della concentrazione della cromogranina A circolante in pazienti con iperplasia prostatica benigna e adenocarcinoma prostatico | 2005 | Destefanis P.; Berruti A.; Zitella A.; Mongozzi G.; Rosso R.; Casetta G.; Aimo P.; Rolle L.; Greco A.; Dogliotti L.; Fontana D.; Tizzani A. | |
| Critical issues in current comparative and cost analyses between retropubic and robotic radical prostatectomy | 2008 | GIANINO M; GALZERANO M; TIZZANI A; GONTERO P |